Table 3.
Observed phenotypic drug resistance per study site
| GKA n = (%) | ALO n = (%) | MAG n = (%) | TOTAL n = (%) | ||
|---|---|---|---|---|---|
| Pan-susceptible | 50 (89.3) | 58 (87.8) | 81 (90.0) | 189 (89.2) | |
| Monoresistant | 5 (8.9) | 3 (4.6) | 6 (6.7) | 14 (6.6) | |
| STR | 1 | 3 | 3 | 7 | |
| INH (0.1 mg/L) | 2 | 0 | 1 | 3 | |
| INH (0.4 mg/L) | 0 | 0 | 1 | 1 | |
| RMP | 2 | 0 | 1 | 3 | |
| Polyresistant | 0 | 2 (3.0) | 1 (1.1) | 3 (1.4) | |
| STR + INH | 0 | 1 | 1 | 2 | |
| STR + RMP | 0 | 1 | 0 | 1 | |
| MDR | 1 (1.8) | 3 (4.6) | 2 (2.2) | 6 (2.8) | |
| INH + RMP | 0 | 0 | 1 | 1 | |
| STR + INH + RMP + EMB | 1 | 0 | 0 | 1 | |
| STR + INH + RMP | 0 | 2 | 0 | 2 | |
| STR + INH + RMP + ETH | 0 | 1 | 0 | 1 | |
| INH + RMP + PZA + ETH | 0 | 0 | 1 | 1 | |
GKA = Goroka, ALO = Alotau, MAG = Madang, STR = Streptomycin, INH = Isoniazid, RMP = Rifampicin, EMB = Ethambutol, ETH = Ethionamide, PZA = Pyrazinamide.